Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Retinal microglia are critical for subretinal neovascular formation
Ayumi Usui-Ouchi, … , Stephen Bravo, Martin Friedlander
Ayumi Usui-Ouchi, … , Stephen Bravo, Martin Friedlander
Published May 21, 2020
Citation Information: JCI Insight. 2020;5(12):e137317. https://doi.org/10.1172/jci.insight.137317.
View: Text | PDF
Research Article Angiogenesis Ophthalmology

Retinal microglia are critical for subretinal neovascular formation

  • Text
  • PDF
Abstract

Abnormal subretinal neovascularization is a characteristic of vision-threatening retinal diseases, including macular telangiectasia (MacTel) and retinal angiomatous proliferation (RAP). Subretinal neovascular tufts and photoreceptor dysfunction are observed in very-low-density lipoprotein receptor (Vldlr–/–) mutant mice. These changes mirror those observed in patients with MacTel and RAP, but the pathogenesis is largely unknown. In this study, we show that retinal microglia were closely associated with retinal neovascular tufts in Vldlr–/– mice and retinal tissue from patients with MacTel; ablation of microglia/macrophages dramatically prevented formation of retinal neovascular tufts and improved neuronal function, as assessed by electroretinography. Vldlr–/– mice with retinal pigmented epithelium–specific (RPE-specific) Vegfa had greatly reduced subretinal infiltration of microglia/macrophages, subsequently reducing neovascular tufts. These findings highlight the contribution of microglia/macrophages to the pathogenesis of neovascularization, provide valuable clues regarding potential causative cellular mechanisms for subretinal neovascularization in patients with MacTel and RAP and suggest that targeting microglia activation may be a therapeutic option in these diseases.

Authors

Ayumi Usui-Ouchi, Yoshihiko Usui, Toshihide Kurihara, Edith Aguilar, Michael I. Dorrell, Yoichiro Ideguchi, Susumu Sakimoto, Stephen Bravo, Martin Friedlander

×

Figure 2

Microglia ablation prevents subretinal neovascularization in Vldlr–/– mice.

Options: View larger image (or click on image) Download as PowerPoint
Microglia ablation prevents subretinal neovascularization in Vldlr–/– mi...
(A–C) Pharmacological microglia ablation using the CSF-1R inhibitor Ki 20227 in Vldlr–/–; Cx3cr1GFP/+ mice. (A) Subretinal neovascular (NV) tufts and GFP-positive microglia/macrophages were analyzed using GS-lectin staining in P17 Vldlr–/–; Cx3cr1GFP/+ mice treated with vehicle or Ki20227 from P10 to 16. Both (B) GFP-positive pixels and (C) the number of subretinal NV tufts were significantly reduced in Ki20227-treated mice retina. The P values were calculated using an unpaired 2-tailed t test (vehicle: n = 4, Ki20227: n = 6). (D and E) Genetic ablation of microglia in Vldlr–/– mice was achieved by crossing Cx3cr1Cre-ERT; Vldlr–/– mice and Rosa26iDTR/+mice. (D) The NV tufts in P23 Rosa26iDTR/+; Vldlr–/– and Cx3cr1 Cre-ERT; Rosa26iDTR/+; Vldlr–/– mice were analyzed by GS-lectin staining after 4-hydroxytamoxifen (4HT) treatment at P10 and P11, followed by P12-P14 diphtheria toxin (DT) treatment, demonstrating a marked reduction of NV tufts in Cx3cr1 Cre-ERT; Rosa26iDTR/+; Vldlr–/– mice (Rosa26iDTR/+; Vldlr–/–: n = 11, Cx3cr1 Cre-ERT; Rosa26iDTR/+; Vldlr–/–: n = 15) (E). Error bars indicate the mean ± SEM. The P values were calculated using an unpaired 2-tailed t test. ****P < 0.0001. Scale bars: 1 mm.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts